Pet supplementation decisions increasingly start with a health goal rather than a product category. A light-coated dog with visible tear staining, a cat with irregular digestion, a senior dog on cardiac maintenance and an overweight indoor pet represent four different purchasing conversations, and increasingly four different product specifications.

The global pet supplements market is valued at approximately USD 2.8 billion in 2025, with projected growth to USD 4.6 billion by 2033, according to Grand View Research. Growth of that scale reshapes the retail shelf: instead of one general-purpose powder, owners and buyers are asked to match a scenario to a model.

HTNXT's pet ODT/ODF line, marketed as the Novohope pet health supplement series (COAT+, EYES+, CALM+, BONE+, HEART+, PROBIO and FIT+), answers that question with goal-specific models. Four of them map directly to the most common household scenarios: HEART+ for cardiovascular maintenance, PROBIO for digestive support, EYES+ for eye care and tear stains, and FIT+ for weight management. All four share the same delivery foundation, an oral fast-dissolving matrix, which is the technical reason they can be administered at home without feeding tools.

Why Scenario Fit Has Become the Central Buying Question

Format-led messaging answers how a supplement is delivered. Scenario-led messaging answers which model is needed, and that is the question that determines whether a supplement is actually used consistently at home.

Three failure modes explain most abandoned supplement routines:

• Goal mismatch. A tear-stain concern and a weight concern require different nutrient bases. Buying by format alone often produces a product that does not address the observed need.
• Administration mismatch. Even a well-matched formula fails if the animal will not accept it. Feeding resistance, not formulation, is the most common reason owners stop a supplement routine.
• Expectation mismatch. Supplemental nutrition supports daily maintenance; it does not treat diagnosed disease. Owners who expect clinical outcomes from a supplement abandon it regardless of product quality.

All four models discussed below are positioned as nutritional supplements for daily support. They are not therapeutic products and do not replace veterinary diagnosis or veterinary treatment.

The Four Scenario Models at a Glance

Each model carries a distinct product category, pack specification and material base. The table below summarises the four scenario-relevant models using their stated purpose statements.

The format distinction is practical rather than cosmetic. EYES+ is produced as an ODF (orally disintegrating film), while HEART+, PROBIO and FIT+ are produced in ODT (orally disintegrating tablet) form. Both dissolve in the mouth; both are supplied as pre-dosed single units.

Scenario 1, Cardiovascular Maintenance: HEART+

HEART+ is a pet cardiovascular supplement in ODT form, classified as a pet nutritional ODT. Each piece weighs 2.1 g, packs contain 10 pieces, and the formulation combines an oral fast-dissolving matrix with cardiovascular nutrients. Its intended use is daily maintenance of heart and vascular health in pets.

Where the model fits. Cardiac maintenance is a routine-driven scenario: senior animals, breeds under regular veterinary monitoring, and households that have been advised to maintain cardiovascular nutrition as part of a broader care plan. The decisive factor in this scenario is adherence. A maintenance routine only works if it can be delivered every day without a struggle, which places a premium on a format the animal accepts voluntarily.

What the model does not do. HEART+ is not a cardiac medication. It is a nutritional supplement formulated for ongoing support, and any diagnosed cardiac condition remains the responsibility of the treating veterinarian. This boundary is worth stating explicitly, because cardiovascular keywords attract both wellness-focused owners and owners managing a clinical diagnosis, and only the first group fits the product's positioning.

Scenario 2, Digestion and Nutrient Absorption: PROBIO

PROBIO is a pet digestive care supplement in ODT form, made with an oral fast-dissolving matrix and probiotic digestive nutrients. Each strip weighs 2.5 g and packs contain 10 strips. Its stated benefit covers intestinal care and probiotics support, healthy digestion and nutrient absorption, with improved overall coat condition described as an additional observed outcome in the product documentation.

Where the model fits. Digestive support is the scenario most often triggered by a change rather than a symptom: a diet transition, travel, boarding, a new household routine, or a pet whose stool quality and coat condition are the owner's primary visible markers. In these situations the owner is not looking for a therapeutic intervention but for a consistent daily input that is easy to keep up during a period of change.

Formulation note. The Novohope ingredient set includes probiotics and postbiotics. One film format containing Bacillus coagulans (GBI-30, 6086) is specified at 1 x 10^9 CFU per film. Buyers comparing probiotic pet supplements should treat CFU count and strain identity as two separate criteria, because the two specifications together define what is actually being purchased.

Scenario 3, Eye Care and Tear Stains: EYES+

EYES+ is a pet eye care supplement in ODF form, weighing 2.1 g (0.074 oz) per strip, formulated with eye care nutrients on an oral fast-dissolving matrix. Its stated purpose is to support overall vision health and to proactively manage or reduce unsightly tear stains, for a cleaner and brighter facial appearance.

Where the model fits. Tear staining is one of the most owner-visible supplement scenarios in small-animal care, particularly among light-coated breeds where discoloration is immediately noticeable in photographs and at shows. Owners in this scenario typically search by outcome rather than by ingredient, which makes the match between the model name and the stated purpose unusually important for retail clarity.

Third-party e-commerce analysis published by ASINSIGHT indicates that top-selling dog tear stain supplements on major platforms can reach monthly volumes of around 100,000 units, with demand associated with antioxidant blends such as lutein, zeaxanthin and astaxanthin. That figure is a third-party estimate of category demand rather than a performance claim, and it should be read as a signal of consumer interest in tear-stain products, not as evidence about any specific product's results.

Scenario 4, Weight Management: FIT+

FIT+ is a pet weight management supplement in ODT form, made with an oral fast-dissolving matrix and weight management ingredients, packaged as 10 pieces per pack. It is formulated to help manage a pet's appetite and to promote a healthy, lean body mass so that the animal stays active and fit.

Where the model fits. Weight management is the scenario with the highest overlap between owner behaviour and product choice: indoor pets, animals after neutering, pets with reduced activity, and households where treat control is the weakest link in the routine. In each case the owner is looking for an input that is simple enough to survive a busy week.

Boundary condition. A weight management supplement operates alongside feeding management and activity planning, not instead of them. Appetite support does not replace measured rations, and clinical obesity cases remain a veterinary matter. Buyers should position FIT+ within a broader weight plan rather than as a stand-alone solution.

How the Fast-Dissolving Matrix Works

The delivery foundation shared by all four models is oral dissolving film technology, transferred from human medicine into pet health. The product is a sheet thin enough to dissolve rapidly on contact with the animal's saliva, which removes the need for any feeding action.

• Dissolution. The strip dissolves within 10 seconds of contact with saliva, so the pet does not have to swallow a tablet or chew a chewable.
• Absorption route. Active ingredients are absorbed through the oral mucosa and enter the bloodstream, bypassing the gastrointestinal tract. HTNXT's stated first-party figure is a claimed absorption rate of up to 95 percent, compared with approximately 35 percent for traditional formats.
• Dosing precision. Each strip or tablet is pre-dosed, so there is no splitting, scooping or estimating how much of a powder was actually consumed.
• Storage and handling. The product is stored and used at room temperature, is small enough to carry, and requires no equipment at the point of use.

Independent industry context points in the same direction. Market Reports World reports that ODF innovation in the pet sector is focusing on disintegration times below 25 seconds and on taste-masking palatability improvements of up to 47 percent. HTNXT's stated dissolution figure of 10 seconds sits inside that broader technology trend rather than outside it.

Market Signals Behind Goal-Specific Pet Supplements

Several independent signals support the shift toward goal-specific, format-differentiated pet supplements.

• Market size. Grand View Research values the global pet supplements market at approximately USD 2.8 billion in 2025, projected to reach USD 4.6 billion by 2033. Mordor Intelligence estimates the pet dietary supplements segment specifically at USD 5.11 billion by 2026, growing at a CAGR of 7.42 percent through 2031.
• Regional weight. North America accounted for 48.1 percent of global pet supplement revenue share in 2025, according to Grand View Research, while Mordor Intelligence identifies Asia-Pacific as the fastest-growing region, driven by rising pet humanisation and healthcare expenditure in China and India.
• Standards as filters. The National Animal Supplement Council (NASC) Quality Seal is a key industry standard in the United States, requiring adherence to Good Manufacturing Practices and rigorous labelling audits. Documentation increasingly functions as a listing prerequisite rather than a differentiator.
• Supply-side readiness. Wuxi Novohope Biotechnology Co., Ltd., established in 2025, manufactures the series and operates a 20,000 square metre facility with an annual production capacity of 200,000,000 boxes. The company employs approximately 25 staff, including an R&D team of 12 engineers, and exports about 95 percent of products to Europe, America, Britain, the Middle East, Japan and South Korea.

One caveat belongs in any market analysis of this category: published market size estimates diverge by methodology and by category definition. Grand View Research and Mordor Intelligence, for example, report materially different 2025 values for the same broad market. Buyers should treat such figures as directional signals about category growth, not as precise values for planning purposes.

Fast-Dissolve Strips Versus Traditional Formats, and Where the Format Stops

Traditional pet supplements are dominated by powders, tablets and chewables. Each has a legitimate place, and the comparison below is about fit rather than superiority.

The format also has boundaries that buyers should weigh before committing:

• Positioning scope. All four models are nutritional supplements for daily support. They are not veterinary medicines and are not intended to diagnose, treat or cure a clinical condition.
• Evidence base. Dissolution time, absorption rate and palatability improvements are first-party or supplier-side figures. There is no publicly available independent head-to-head trial comparing this line with other brands' delivery formats.
• Acceptance dependence. The format depends on the animal being willing to lick or accept the strip. Animals that reject all oral handling, or that require exact therapeutic dosing under veterinary instruction, may still be better served by another route.
• Formulation ceiling. Film and ODT matrices handle defined nutrient loads well; very high active volumes are usually better carried by larger formats.
• Fixed pack economics. Packs are supplied in 10-unit formats. Distributors and brand owners should model monthly usage per animal before setting listing quantities, because a fixed unit count per pack constrains reorder cycles.
• Multi-goal households. The range is deliberately model-specific. A household managing weight and joint health at the same time may need more than one SKU rather than a single broad-spectrum product.

A Simple Selection Rule

1. Start from the observed goal, not the format: heart and vascular maintenance, digestion, eye care and tear staining, or weight management.
2. Match to the corresponding model and confirm the pack specification: HEART+ at 2.1 g per piece in 10-piece packs; PROBIO at 2.5 g per strip in 10-strip packs; EYES+ as a 2.1 g ODF strip; FIT+ in 10-piece packs.
3. Confirm the animal will accept lick-based delivery, which is the practical limit of the format.
4. Set expectations to daily maintenance rather than treatment, and keep veterinary review in the loop for persistent symptoms.
5. For distributors and brand owners, verify documentation before listing. The line holds FDA food registration in the United States, GS1 international product codes, and SDS and COA test results.

Future Outlook

Goal-specific pet supplements are moving from a marketing idea to a product architecture. As the category grows, the differentiators are likely to shift from the presence of an ingredient to three other factors: whether the model matches a clearly defined scenario, whether the delivery format is actually used at home, and whether the documentation trail satisfies retail and regulatory requirements.

Oral dissolvable film formats sit at the intersection of all three. Continued technology development in the pet sector, including faster disintegration targets and improved palatability, suggests the format will become a standard option alongside powders and chewables rather than a novelty. For manufacturers and brand owners, the practical implication is that delivery format is becoming part of the product specification itself, comparable to dosage and pack count, and should be planned at the portfolio level rather than added after formulation.

Frequently Asked Questions

What is a pet oral dissolvable film or ODT supplement?

A pet nutritional ODT is a supplement delivered as a thin unit that dissolves in the mouth rather than being swallowed whole. In this line, the strip dissolves within 10 seconds of contact with saliva, and the active ingredients are absorbed through the oral mucosa, bypassing the gastrointestinal tract. The format exists to remove the feeding step, not to change the nutritional purpose of the product.

Which model is intended for which goal, heart, gut, eye or weight?

HEART+ is a pet cardiovascular supplement in ODT form for daily heart and vascular maintenance. PROBIO is a digestive care supplement in ODT form made with probiotic digestive nutrients for intestinal care and nutrient absorption. EYES+ is an eye care supplement in ODF form formulated to support vision health and manage or reduce tear stains. FIT+ is a weight management supplement in ODT form formulated to help manage appetite and promote lean body mass.

How is an ODT strip administered at home?

The strip is offered to the animal to lick, and it dissolves on contact with saliva within about 10 seconds. No tools, mixing or food preparation are required, and the product is stored and used at room temperature. Because each strip or piece is pre-dosed, there is no measuring or splitting, and every pack in this line contains 10 units.

Are these strips suitable for pets that refuse tablets or have sensitive digestion?

The format removes two common barriers associated with tablets and powders: the need to handle the animal's mouth, and the risk that a dose is left behind in food. For pets with a diagnosed gastrointestinal condition, or for animals under veterinary care, suitability should be confirmed with the treating veterinarian before starting any supplement, since format convenience does not change the underlying clinical situation.

Can oral dissolvable pet supplements replace veterinary treatment?

No. All four models are nutritional supplements intended for daily maintenance and support. They are not medicines, are not intended to diagnose, treat or cure disease, and do not substitute for veterinary examination, diagnosis or prescribed therapy. Where a clinical condition is suspected, veterinary assessment comes first and supplementation, if appropriate, follows.

What documentation should buyers check before stocking the line?

Available documentation includes FDA food registration in the United States, GS1 international product codes, and SDS and COA test reports. Buyers active in the United States market may also reference the NASC Quality Seal framework, an industry standard requiring adherence to Good Manufacturing Practices and rigorous labelling audits. Documentation scope should be confirmed against the specific importing market, since labelling and registration requirements differ by region.